Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis.

JAMA network open - 2 Dec 2019

Na Rong, Labbate Craig, Yu Hongjie, Shi Zhuqing, Fantus Richard J, Wang Chi-Hsiung, Andriole Gerald L, Isaacs William B, Zheng S Lilly, Helfand Brian T, Xu Jianfeng

Abstract excerpt

Importance: Few studies have evaluated the association between a single-nucleotide polymorphism-based genetic risk score (GRS) and patient age at prostate cancer (PCa) diagnosis. Objectives: To test the association between a GRS and patient age at PCa diagnosis and to compare the performance of a GRS with that of family history (FH) in PCa risk stratification. Design, Setting, and Participants: A cohort study of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to Cohort Studies

Share to Medical History Taking

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 31880795
DOI: 10.1001/jamanetworkopen.2019.18145
PMCID: PMC6991229

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis.PMID 31880795Read ↗

A genetic risk score to guide age-specific, personalized prostate cancer screeningSemantic proximity Read ↗

Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial.Semantic proximity Read ↗

Development and validation of a simple prostate cancer risk prediction model based on age, family history, and polygenic risk.Semantic proximity Read ↗

A comparison of genetic risk score with family history for estimating prostate cancer risk.Semantic proximity Read ↗

Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis.Semantic proximity Read ↗

Influence of age on predictiveness of genetic risk score for prostate cancer in a Chinese hospital-based biopsy cohort.Semantic proximity Read ↗

Improved prostate cancer prediction by combining Prostate-Specific Antigen (PSA) test results with Genetic Risk Scores (GRS/PRS)Semantic proximity Read ↗

The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making.Semantic proximity Read ↗

Germline Genetics of Prostate Cancer: Time to Incorporate Genetics into Early Detection ToolsSemantic proximity Read ↗

Clinical validity and utility of genetic risk scores in prostate cancer.Semantic proximity Read ↗

Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer.Semantic proximity Read ↗

Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.